A	O
single	O
session	O
of	O
exhaustive	O
exercise	O
markedly	O
decreases	O
circulating	O
levels	O
of	O
guanidinoacetic	B:C0061626
acid	I:C0061626
in	O
healthy	O
men	O
and	O
women	O
.	O

A	O
single	O
session	O
of	O
exhaustive	O
exercise	O
markedly	O
decreases	O
circulating	O
levels	O
of	O
guanidinoacetic	O
acid	I:C0061626
in	O
healthy	O
men	B:C0025266
and	O
women	O
.	O

A	O
single	O
session	O
of	O
exhaustive	O
exercise	O
markedly	O
decreases	O
circulating	O
levels	O
of	O
guanidinoacetic	O
acid	I:C0061626
in	O
healthy	O
men	O
and	O
women	B:C0043210
.	O

We	O
evaluated	B:C0220825
the	O
effects	O
of	O
exercise	O
on	O
circulating	O
concentrations	O
of	O
guanidinoacetic	O
acid	I:C0061626
(	O
guanidinoacetic	O
acid	I:C0061626
)	O
and	O
creatine	O
in	O
23	O
healthy	O
volunteers	I:C3661466
subjected	O
to	O
running	O
to	O
exhaustion	O
and	O
free	O
-	O
weight	O
bench	O
-	O
press	O
to	O
volitional	O
failure	O
.	O

We	O
evaluated	O
the	O
effects	O
of	O
exercise	O
on	O
circulating	O
concentrations	O
of	O
guanidinoacetic	B:C0061626
acid	I:C0061626
(	O
guanidinoacetic	O
acid	I:C0061626
)	O
and	O
creatine	O
in	O
23	O
healthy	O
volunteers	I:C3661466
subjected	O
to	O
running	O
to	O
exhaustion	O
and	O
free	O
-	O
weight	O
bench	O
-	O
press	O
to	O
volitional	O
failure	O
.	O

We	O
evaluated	O
the	O
effects	O
of	O
exercise	O
on	O
circulating	O
concentrations	O
of	O
guanidinoacetic	O
acid	I:C0061626
(	O
guanidinoacetic	B:C0061626
acid	I:C0061626
)	O
and	O
creatine	O
in	O
23	O
healthy	O
volunteers	I:C3661466
subjected	O
to	O
running	O
to	O
exhaustion	O
and	O
free	O
-	O
weight	O
bench	O
-	O
press	O
to	O
volitional	O
failure	O
.	O

We	O
evaluated	O
the	O
effects	O
of	O
exercise	O
on	O
circulating	O
concentrations	O
of	O
guanidinoacetic	O
acid	I:C0061626
(	O
guanidinoacetic	O
acid	I:C0061626
)	O
and	O
creatine	B:C0010286
in	O
23	O
healthy	O
volunteers	I:C3661466
subjected	O
to	O
running	O
to	O
exhaustion	O
and	O
free	O
-	O
weight	O
bench	O
-	O
press	O
to	O
volitional	O
failure	O
.	O

We	O
evaluated	O
the	O
effects	O
of	O
exercise	O
on	O
circulating	O
concentrations	O
of	O
guanidinoacetic	O
acid	I:C0061626
(	O
guanidinoacetic	O
acid	I:C0061626
)	O
and	O
creatine	O
in	O
23	O
healthy	B:C3661466
volunteers	I:C3661466
subjected	O
to	O
running	O
to	O
exhaustion	O
and	O
free	O
-	O
weight	O
bench	O
-	O
press	O
to	O
volitional	O
failure	O
.	O

We	O
evaluated	O
the	O
effects	O
of	O
exercise	O
on	O
circulating	O
concentrations	O
of	O
guanidinoacetic	O
acid	I:C0061626
(	O
guanidinoacetic	O
acid	I:C0061626
)	O
and	O
creatine	O
in	O
23	O
healthy	O
volunteers	I:C3661466
subjected	O
to	O
running	O
to	O
exhaustion	B:C0392674
and	O
free	O
-	O
weight	O
bench	O
-	O
press	O
to	O
volitional	O
failure	O
.	O

Blood	B:C0005767
was	O
taken	O
before	O
and	O
following	O
each	O
exercise	O
session	O
.	O

Running	O
induced	O
a	O
significant	O
decrease	O
in	O
serum	B:C0229671
guanidinoacetic	O
acid	I:C0061626
by	O
20.1	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
while	O
free	O
-	O
weight	O
exercise	O
reduced	O
guanidinoacetic	O
acid	I:C0061626
by	O
11.7	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
suggesting	O
the	O
possible	O
use	O
of	O
serum	O
guanidinoacetic	O
acid	I:C0061626
as	O
a	O
novel	O
biomarker	O
of	O
exhaustion	O
.	O

Running	O
induced	O
a	O
significant	O
decrease	O
in	O
serum	O
guanidinoacetic	B:C0061626
acid	I:C0061626
by	O
20.1	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
while	O
free	O
-	O
weight	O
exercise	O
reduced	O
guanidinoacetic	O
acid	I:C0061626
by	O
11.7	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
suggesting	O
the	O
possible	O
use	O
of	O
serum	O
guanidinoacetic	O
acid	I:C0061626
as	O
a	O
novel	O
biomarker	O
of	O
exhaustion	O
.	O

Running	O
induced	O
a	O
significant	O
decrease	O
in	O
serum	O
guanidinoacetic	O
acid	I:C0061626
by	O
20.1	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
while	O
free	O
-	O
weight	O
exercise	O
reduced	O
guanidinoacetic	B:C0061626
acid	I:C0061626
by	O
11.7	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
suggesting	O
the	O
possible	O
use	O
of	O
serum	O
guanidinoacetic	O
acid	I:C0061626
as	O
a	O
novel	O
biomarker	O
of	O
exhaustion	O
.	O

Running	O
induced	O
a	O
significant	O
decrease	O
in	O
serum	O
guanidinoacetic	O
acid	I:C0061626
by	O
20.1	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
while	O
free	O
-	O
weight	O
exercise	O
reduced	O
guanidinoacetic	O
acid	I:C0061626
by	O
11.7	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
suggesting	O
the	O
possible	O
use	O
of	O
serum	B:C0229671
guanidinoacetic	O
acid	I:C0061626
as	O
a	O
novel	O
biomarker	O
of	O
exhaustion	O
.	O

Running	O
induced	O
a	O
significant	O
decrease	O
in	O
serum	O
guanidinoacetic	O
acid	I:C0061626
by	O
20.1	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
while	O
free	O
-	O
weight	O
exercise	O
reduced	O
guanidinoacetic	O
acid	I:C0061626
by	O
11.7	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
suggesting	O
the	O
possible	O
use	O
of	O
serum	O
guanidinoacetic	B:C0061626
acid	I:C0061626
as	O
a	O
novel	O
biomarker	O
of	O
exhaustion	O
.	O

Running	O
induced	O
a	O
significant	O
decrease	O
in	O
serum	O
guanidinoacetic	O
acid	I:C0061626
by	O
20.1	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
while	O
free	O
-	O
weight	O
exercise	O
reduced	O
guanidinoacetic	O
acid	I:C0061626
by	O
11.7	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
suggesting	O
the	O
possible	O
use	O
of	O
serum	O
guanidinoacetic	O
acid	I:C0061626
as	O
a	O
novel	O
biomarker	B:C0005516
of	O
exhaustion	O
.	O

Running	O
induced	O
a	O
significant	O
decrease	O
in	O
serum	O
guanidinoacetic	O
acid	I:C0061626
by	O
20.1	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
while	O
free	O
-	O
weight	O
exercise	O
reduced	O
guanidinoacetic	O
acid	I:C0061626
by	O
11.7	O
%	O
(	O
P	O
<	O
0.001	O
)	O
,	O
suggesting	O
the	O
possible	O
use	O
of	O
serum	O
guanidinoacetic	O
acid	I:C0061626
as	O
a	O
novel	O
biomarker	O
of	O
exhaustion	B:C0392674
.	O

